Our Mission

Our Mission is to make a significant global impact in helping to reduce maternal death worldwide. We aim to support at every delivery across the world through access to a safe and clinically effective technology which is fast acting in all conditions providing versatility and ease of use.

Learn More

World Numbers

20%Failure rates of existing devices¹

14mWomen impacted Globally by PPH⁵

20%Maternal deaths due to PPH worldwide⁶

80kAnnual Deaths caused by PPH⁷

Postpartum Haemorrhage is the leading cause of maternal mortality worldwide representing over 80,000 deaths worldwide.

7.2% to 25.7%Rate of PPH (Blood loss >500ml) across all global markets⁸

The rate of PPH varies significantly across both low income and developed nations with an incidence ranging from 7.2% to 25.7% variable by geographic region (defined as >500ml blood loss in vaginal births) representing over 14 million pregnant woman who suffer from this condition.

With such significant global challenges associated with PPH we are passionate about supporting research and development across reproductive health, with a versatile, easy to use, cost effective, clinically successful device.

Learn More

See CELOX™ PPH Here

Dubai World Trade Centre

29 January 2024 to
1 February 2024

Arab Health

More Details

Fast acting Safe and clinically effective Versatile and Easy to use

UK Office

Medtrade Products Ltd,
Electra House,
Crewe Business Park,
Crewe, Cheshire, England,
CW1 6GL

Tel: +44 (0)1270 500 019
Email: info@celoxpph.com

Approval Ref: MT-23-390

References

We have gathered all the references together and listed them on a page for clarity. View All References